Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lantern Pharma Inc
(NQ:
LTRN
)
4.440
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lantern Pharma Inc
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Monday's Intraday Session
March 11, 2024
Via
Benzinga
Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET
March 11, 2024
From
Lantern Pharma Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
March 08, 2024
Via
Benzinga
Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday
March 06, 2024
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Lantern Pharma: Q3 Earnings Insights
November 08, 2023
Via
Benzinga
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 06, 2024
Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.
Via
Benzinga
Lantern To Participate in H.C Wainwright & Co.’s (HCW) 1st Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference
March 05, 2024
From
Lantern Pharma Inc.
Via
Business Wire
A Preview Of Lantern Pharma's Earnings
November 07, 2023
Via
Benzinga
Lantern Pharma's A.I. Platform, RADR®, Surpasses 60 Billion Data Points – Anticipates Reaching 100 Billion Data Points in 2024, Paving the Way for Enhanced Cancer Therapy Innovations and Expedited Development Timelines
March 04, 2024
From
Lantern Pharma Inc.
Via
Business Wire
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
March 04, 2024
Grand View Research says the global
Via
Talk Markets
3 AI Powerhouses Predicted to Soar 500% in the Next Tech Boom
February 20, 2024
Discover how these AI powerhouses are leveraging AI in the IT consulting, application software, and biotech industries.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
February 19, 2024
The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Lantern Pharma Advances Unique ADC (Antibody Drug Conjugate) Program Across Multiple Solid Tumor Cancers
February 15, 2024
From
Lantern Pharma Inc.
Via
Business Wire
Starlight Therapeutics, a Subsidiary of Lantern Pharma Focused on CNS & Brain Cancers, Announces Dr. Marc Chamberlain as Chief Medical Officer
January 17, 2024
From
Lantern Pharma
Via
Business Wire
AI-Focused Drug Discovery Stocks Index Up 26% In December
December 29, 2023
With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions.
Via
Talk Markets
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 18, 2023
Via
Benzinga
AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week
December 17, 2023
A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
The 3 Most Undervalued AI Penny Stocks to Buy in December
December 13, 2023
These AI penny stocks offer substantial returns to investors as the market continues to grow at a rapid pace.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in High-Grade B-cell Lymphomas (HGBL)
November 30, 2023
From
Lantern Pharma Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
November 09, 2023
Via
Benzinga
Lantern Pharma Reports Third Quarter 2023 Financial Results and Operational Highlights
November 08, 2023
From
Lantern Pharma Inc.
Via
Business Wire
Lantern Pharma to Report Third Quarter 2023 Operating & Financial Results on November 8th, 2023 at 4:30 p.m. ET
November 01, 2023
From
Lantern Pharma Inc.
Via
Business Wire
The 7 Most Undervalued AI Penny Stocks to Buy: October 2023
October 24, 2023
Unlock exponential growth with the next big undervalued AI penny stocks to buy, offering tremendous upside ahead.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Lantern Pharma to Present at the ThinkEquity Conference on October 19 at 1:30 p.m. ET
October 10, 2023
From
Lantern Pharma Inc.
Via
Business Wire
Lantern Pharma Announces Publication in Clinical Cancer Research Highlighting the Enhanced Efficacy of LP-184 in Glioblastoma
October 03, 2023
From
Lantern Pharma
Via
Business Wire
Lantern Pharma Announces First Patient Dosed in the Phase 1 Study for LP-184 in Advanced Solid Tumors
September 25, 2023
From
Lantern Pharma Inc.
Via
Business Wire
Lantern Pharma Receives IND Clearance from FDA Enabling Phase 1 Initiation for Drug Candidate LP-284 in Non-Hodgkin’s Lymphomas
September 18, 2023
From
Lantern Pharma Inc.
Via
Business Wire
The 3 Most Undervalued Machine Learning Stocks to Buy in September 2023
September 14, 2023
Here are three machine-learning stocks that may be ready to move much higher when investor sentiment changes.
Via
InvestorPlace
Lantern Pharma to Present Data Highlighting the Anti-Tumor Potency of Drug Candidate LP-284 in Non-Hodgkin’s Lymphomas at the Society of Hematologic Oncology Annual Meeting
August 31, 2023
From
Lantern Pharma Inc.
Via
Business Wire
3 AI Stocks That Still Trade Under $10 Per Share
August 28, 2023
With the artificial intelligence (AI) boom ramping up, check out this short list of hot AI stocks under $10.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.